4 Calculating supplement doses

It is generally expected that many intracellular deficiencies for eg. silicon, magnesium, iodine, selenium, molybdenum, copper, zinc and others may show in your CMA and / or Oligoscan data (and that functional deficiencies for iron, manganese, copper and six others may exist in any HTMA data, indicating inflammation severity over time.)

Assuming inflammation and pH imbalances are correctly managed, resolving these deficiencies may take, eg.
2 or more months, via non-oral routes, eg. sublingual / transdermal / rectal.
1 - 2 weeks via appropriately dosed parenteral administration. This can then be easily maintained via non-oral routes.
NB. These deficiencies are likely not going to resolve at all using standard oral dosing, due to mineral transport inhibition in the duodenum.

If your Oligoscan and/or OAT data shows low phosphorus, the upstream causes for this need to be addressed as a priority, or else remineralisation will be highly problematic. Common upstream influences include the various issues affecting mitochondrial metabolism, to the point of triggering lactic acid metabolism (anaerobic glycolysis). Some of these include insufficient pacing, zinc status, oxidative stress support and oxygen transport / coagulation.

If you are using the custom troches, a number of these minerals and various vitamins are combined in a sublingual dose, which greatly simplifies this part of the protocol. The default formulation should suffice for most people, unless your transferrin saturation is at or above 40%, in which case you would reduce the ferritin content to zero. Where the transferrin saturation exceeds 45%, ie. "iron overload", checking for and remediating cobalt deficiency is suggested, along with excluding any causes of methemoglobinemia. (see “4.2 Custom troches” section)

Please recheck your CMA / Oligoscan for progress on remineralisation regularly (and HTMA, as desired, for progress on inflammation, strontium and rubidium). Adjust mineral supplements as needed if remineralisation is slow. There appears to be a bell curve response for absorption of many metals, where around 5-10% of the total system stores is the upper limit, per day and further efforts result in active blockade. Similarly, absorbing a reasonable amount of excess minerals is not normally problematic unless you have, for example, Wilson’s disease, hemochromatosis or beta thalassemia. These diseases are rare, however need careful management.

Where an element is indicated as non-optimal, you can use these suggested (elemental) minimum daily doses below, relative to the interpreted lower threshold.

NEW: An Oligoscan report analysis tool can be found here.

Based on our collected data, we interpret Oligoscan / SO/Check reports using different upper and lower thresholds than the provider’s report layout indicates.

For Oligoscan reports, VISUALLY, the "Low"  threshold is relocated to halfway between the original Low and OK vertical lines, (ie. where the “a” in “Normal” is located, to the left of “OK”) and the "High" for all markers except fluorine is relocated to halfway between OK and original High vertical lines (ie. where the “o” in “Normal+” is located, to the right of “OK”).

Numerically, if you wanted to do this computationally, Oligoscan "Low" and "High" threshold values for each marker would be recalculated as:
Low=(((Low+High)/2)+Low)/2
High=(((Low+High)/2)+High)/2

NB. According to the 2024 Oligoscan practitioner's guide^*, due to an unusual quirk in methodology / reporting, highly elevated minerals (to the right of our vertical blue line / upper threshold in the image below and usually indicated as yellow or red bar) need to be re-interpreted as highly deficient. This also applied to SO-Check reports. If you see this anomaly in your data, it would be advisable to confirm this by taking a CMA test, if possible. Otherwise, default to reinterpreting the marker as proportionally "low".
^*The practitioner's guide discusses zinc transport blockade as the reason for the marker elevation. From our comparisons with CMA data, the issue also applies to other markers and appears to be something do to with the "trade secret" Oligoscan algorithm. Ultimately, I think this could be improved.